Richard Glowacki, MD
Urology · Des Moines, IANPI 1679567663
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,740 of the $11,661 with a category attached, or 66.4%. 41 manufacturers reported payments, led by Intuitive Surgical at 39.2% of the total. Reporting peaked in 2020 at $3,890 and has fallen 74.5% since, to $991 in 2025.
Across 241 payments — averaging $48.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Boston Scientific$1K
- Neotract Inc.$680
- Johnson & Johnson$507
- Teleflex LLC$424
- Dornier Medtech America, Inc$411
- plus $4K from 35 others
What the payments were for
- Travel & lodging$2,40221%
- Food & beverage$7,74066%
- Education$1,51013%
- Gifts$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 25 | $4,570 |
| Boston Scientific | 23 | $1,294 |
| Neotract Inc. | 12 | $680 |
| Johnson & Johnson | 11 | $507 |
| Teleflex LLC | 6 | $424 |
| Dornier Medtech America, Inc | 3 | $411 |
| Sumitomo Pharma America, Inc. | 19 | $327 |
| Urogen Pharma, Inc. | 9 | $262 |
| AbbVie(2 entities) | 12 | $246 |
| Ferring Pharmaceuticals Inc. | 3 | $216 |
| Astellas Pharma US Inc | 10 | $214 |
| Telix Pharmaceuticals | 5 | $197 |
| Myovant Sciences Inc. | 7 | $184 |
| Medtronic | 3 | $168 |
| Pfizer | 9 | $166 |
| Accord Healthcare, Inc. | 4 | $164 |
| Dendreon Pharmaceuticals LLC | 6 | $155 |
| Procept Biorobotics Corporation | 3 | $140 |
| Bayer | 7 | $124 |
| KARL Storz Endoscopy-america | 3 | $122 |
| Merck | 7 | $120 |
| E.r. Squibb & Sons, L.L.C. | 6 | $104 |
| Olympus America Inc. | 4 | $91 |
| Endo USA, Inc. | 5 | $90 |
| Amgen | 5 | $78 |
| Myriad Genetic Laboratories, Inc. | 4 | $64 |
| Axonics, Inc. | 3 | $63 |
| Endo Pharmaceuticals Inc. | 4 | $62 |
| Verity Pharmaceuticals Inc. | 3 | $60 |
| Progenics Pharmaceuticals, Inc. | 4 | $58 |
| Conmed Corporation | 2 | $53 |
| Coloplast | 3 | $48 |
| Tolmar, Inc. | 2 | $36 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Calyxo, Inc. | 1 | $25 |
| Novartis | 1 | $23 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $19 |
| BD | 1 | $17 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $16 |
| Urovant Sciences Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,139
- AMS$349
- UroLift$221
- Dornier MedTech$195
- ADSTILADRIN$164
- INTERSTIM$127
- Lithotripters & Accessories$119
- REZUM$117
- ORGOVYX$116
- JELMYTO$113
- GENERAL BPH$111
- Erleada$111
How this compares
$11,661 in reported general payments places this provider in the 85th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 104 | $1,400,008 |
| ErleadaApalutamide | 46 | $675,370 |
| OrgovyxRelugolix | 29 | $76,731 |
| MyrbetriqMirabegron | 55 | $33,314 |
| Abiraterone Acetate | 14 | $12,665 |
| Tamsulosin Hcl | 511 | $4,368 |
| Solifenacin Succinate | 97 | $3,015 |
| Methenamine Hippurate | 15 | $732 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 31 | $598 |
| Finasteride | 90 | $590 |
| Oxybutynin Chloride ErOxybutynin Chloride | 47 | $401 |
| Doxazosin Mesylate | 11 | $228 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $221 |
| Ciprofloxacin Hcl | 68 | $210 |
| Prednisone | 14 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $214 | $1,433,323159 claims |
| Johnson & JohnsonErleada | $507 | $675,37046 claims |
| Sumitomo Pharma America, Inc.Orgovyx | $327 | $76,73129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 114 urology providers in Iowa.
Other urology in Des Moines
- Kevin BirusinghDes Moines$59K
- Ryan SchulteDes Moines$3K
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
- Ryan DornbierClive$55K
- Alexandria HertzIowa City$53K
- John BuieIowa City$52K
- Charles SchlaepferIowa City$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.